113
Views
31
CrossRef citations to date
0
Altmetric
Review

Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer

, , , , , , & show all
Pages 4593-4606 | Published online: 26 Jun 2017

References

  • SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
  • MarronMBoffettaPZhangZFCessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer riskInt J Epidemiol201039118219619805488
  • ToporcovTNZnaorAZhangZFRisk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortiumInt J Epidemiol201544116918525613428
  • HuangSHO’SullivanBOral cancer: current role of radiotherapy and chemotherapyMed Oral Patol Oral Cir Bucal2013182e233e24023385513
  • RiveraCEssentials of oral cancerInt J Clin Exp Pathol201589118841189426617944
  • IrimieAIBraicuCCojocneanu-PetricRBerindan-NeagoeICampianRSNovel technologies for oral squamous carcinoma biomarkers in diagnostics and prognosticsActa Odontol Scand201573316116825598447
  • CalixtoGBernegossiJFonseca-SantosBChorilliMNanotechnology-based drug delivery systems for treatment of oral cancer: a reviewInt J Nanomedicine201493719373525143724
  • BertrandNWuJXuXKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Deliv Rev20146622524270007
  • JainRKStylianopoulosTDelivering nanomedicine to solid tumorsNat Rev Clin Oncol201071165366420838415
  • LiYWangJWientjesMGAuJLDelivery of nanomedicines to extracellular and intracellular compartments of a solid tumorAdv Drug Deliv Rev2012641293921569804
  • BraicuCCojocneanu-PetricRChiraSClinical and pathological implications of miRNA in bladder cancerInt J Nanomedicine20151079180025653521
  • AgostinelliEVianelloFMagliuloGThomasTThomasTJNanoparticle strategies for cancer therapeutics: Nucleic acids, polyamines, bovine serum amine oxidase and iron oxide nanoparticles (review)Int J Oncol201546151625333509
  • ChoKWangXNieSChenZGShinDMTherapeutic nanoparticles for drug delivery in cancerClin Cancer Res20081451310131618316549
  • SuriSSFenniriHSinghBNanotechnology-based drug delivery systemsJ Occup Med Toxicol200721618053152
  • DevalapallyHChakilamAAmijiMMRole of nanotechnology in pharmaceutical product developmentJ Pharm Sci200796102547256517688284
  • MishraBChaurasiaSDesign of novel chemotherapeutic delivery systems for colon cancer therapy based on oral polymeric nanoparticlesTher Deliv201781294727982736
  • ArachchigeMCReshetnyakYKAndreevOAAdvanced targeted nanomedicineJ Biotechnol2015202889725615945
  • AnselmoACMitragotriSAn overview of clinical and commercial impact of drug delivery systemsJ Control Release2014190152824747160
  • DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
  • OhNParkJHEndocytosis and exocytosis of nanoparticles in mammalian cellsInt J Nanomedicine20149Suppl 1516324872703
  • YangQXuEDaiJA novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancerToxicol App Pharmacol201528527988
  • RejmanJOberleVZuhornISHoekstraDSize-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosisBiochem J2004377Pt 115916914505488
  • BathoriGCervenakLKaradiICaveolae: an alternative endocytotic pathway for targeted drug deliveryCrit Rev Ther Drug Carrier Syst2004212679515202927
  • GeorgievaJVKalicharanDCouraudPOSurface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitroMol Ther201119231832521045812
  • IversenTGSkotlandTSandvigKEndocytosis and intracellular transport of nanoparticles: present knowledge and need for future studiesNano Today201162176185
  • KumariSMgSMayorSEndocytosis unplugged: multiple ways to enter the cellCell Res201020325627520125123
  • ZhangSGaoHBaoGPhysical principles of nanoparticle cellular endocytosisACS Nano2015998655867126256227
  • HillaireauHCouvreurPNanocarriers’ entry into the cell: relevance to drug deliveryCell Mol Life Sci200966172873289619499185
  • TorchilinVPTat peptide-mediated intracellular delivery of pharmaceutical nanocarriersAdv Drug Deliv Rev2008604–554855818053612
  • RapoportMLorberboum-GalskiHTAT-based drug delivery system: new directions in protein delivery for new hopes?Expert Opin Drug Deliv20096545346319413454
  • KunisawaJMasudaTKatayamaKFusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene releaseJ Control Release2005105334435315936842
  • MaCShiLHuangYNanoparticle delivery of Wnt-1 siRNA enhances photodynamic therapy by inhibiting epithelial-mesenchymal transition for oral cancerBiomater Sci20175349450128070573
  • AkbarzadehARezaei-SadabadyRDavaranSLiposome: classification, preparation, and applicationsNanoscale Res Lett20138110223432972
  • SzebeniJComplement activation-related pseudoallergy: a new class of drug-induced acute immune toxicityToxicology20052162–310612116140450
  • KontermannREImmunoliposomes for cancer therapyCurr Opin Mol Ther200681394516506524
  • SamadASultanaYAqilMLiposomal drug delivery systems: an update reviewCurr Drug Deliv20074429730517979650
  • Perez-HerreroEFernandez-MedardeAAdvanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapyEur J Pharm Biopharm201593527925813885
  • TorchilinVPMicellar nanocarriers: pharmaceutical perspectivesPharm Res200724111617109211
  • LuYParkKPolymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugsInt J Pharm2013453119821422944304
  • WolinskyJBGrinstaffMWTherapeutic and diagnostic applications of dendrimers for cancer treatmentAdv Drug Deliv Rev20086091037105518448187
  • WangXWangYChenZGShinDMAdvances of cancer therapy by nanotechnologyCancer Res Treat200941111119688065
  • RaoJPGeckelerKEPolymer nanoparticles: preparation techniques and size-control parametersProg Polym Sci2011367887913
  • PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
  • LiCGeXWangLConstruction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: a synergistic combination nanotherapy for cervical cancerBiomed Pharmacother20178662863628027539
  • AjorlouEKhosroushahiAYTrends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumorsCancer Chemother Pharmacol201779225126527744564
  • MazzarinoLLoch-NeckelGBubniakLSCurcumin-loaded chitosan-coated nanoparticles as a new approach for the local treatment of oral cavity cancerJ Nanosci Nanotechnol201515178179126328442
  • WangZQLiuKHuoZJA cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapyJ Nanobiotechnology2015136326427800
  • WolfbeisOSAn overview of nanoparticles commonly used in fluorescent bioimagingChem Soc Rev201544144743476825620543
  • MuhlfeldCRothen-RutishauserBVanheckeDBlankFGehrPOchsMVisualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopyPart Fibre Toxicol200741117996124
  • YaoHKimuraKField emission scanning electron microscopy for structural characterization of 3D gold nanoparticle superlatticesMéndez-VilasADíazJModern Research and Educational Topics in MicroscopyBadajoz, SpainFormatex2007568575
  • ArulmozhiVPandianKMirunaliniSEllagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB)Colloids Surf B Biointerfaces201311031332023732810
  • EnglandCGHernandezREddineSBCaiWMolecular imaging of pancreatic cancer with antibodiesMol Pharm201613182426620581
  • SaadatpourZRezaeiAEbrahimnejadHImaging techniques: new avenues in cancer gene and cell therapyCancer Gene Ther20172411527834357
  • XinYLiuTYangCDevelopment of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug deliveryInt J Nanomedicine2016115807582127853366
  • DevarajNKKeliherEJThurberGMNahrendorfMWeisslederR18F labeled nanoparticles for in vivo PET-CT imagingBioconjug Chem200920239740119138113
  • de JongMEssersJvan WeerdenWMImaging preclinical tumour models: improving translational powerNat Rev Cancer201414748149324943811
  • BlackKCAkersWJSudlowGXuBLaforestRAchilefuSDual-radiolabeled nanoparticle SPECT probes for bioimagingNanoscale20157244044425418982
  • MorelliJNRungeVMAiFAn image-based approach to understanding the physics of MR artifactsRadiographics201131384986621571661
  • PooleyRAAAPM/RSNA physics tutorial for residents: fundamental physics of MR imagingRadiographics20052541087109916009826
  • VigariosEEpsteinJBSibaudVOral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitorsSupport Care Cancer20172551713173928224235
  • NejadSMTakahashiHHosseiniHAcute effects of sono-activated photocatalytic titanium dioxide nanoparticles on oral squamous cell carcinomaUltrason Sonochem2016329510127150750
  • LinLTChangCYChangCHInvolvement of Let-7 microRNA for the therapeutic effects of rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer modelOncotarget2016740657826579627588466
  • KrishnakumarNSulfikkaraliNKManoharanSVenkatachalamPRaman spectroscopic investigation of the chemopreventive response of naringenin and its nanoparticles in DMBA-induced oral carcinogenesisSpectrochim Acta A Mol Biomol Spectrosc201311564865323880406
  • HirshbergAAllonINovikovIAnkriRAshkenazyAFixlerDGold nanorods reflectance discriminate benign from malignant oral lesionsNanomedicine20171341333133928115253
  • AnkriRAshkenazyAMilsteinYGold nanorods based air scanning electron microscopy and diffusion reflection imaging for mapping tumor margins in squamous cell carcinomaACS Nano20161022349235626759920
  • SantoroAPapagerakisSSerpicoRGuidaAMuzioLBufoPEpigenetic profiling of oral cancerOgburekeKUOral CancerRijeka, CroatiaInTech2012297326
  • MahakianLMFarwellDGZhangHComparison of PET imaging with 64Cu-liposomes and 18F-FDG in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch model of oral dysplasia and squamous cell carcinomaMol Imaging Biol201416228429224019092
  • ZhangWGargSEldiPTargeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptideInt J Pharm20165131–227027927633281
  • SawantSDongreHSinghAKEstablishment of 3D co-culture models from different stages of human tongue tumorigenesis: utility in understanding neoplastic progressionPloS One2016118e016061527501241
  • GuggenheimEJKhanAPikeJChangLLynchIRappoportJZComparison of confocal and super-resolution reflectance imaging of metal oxide nanoparticlesPloS One20161110e015998027695038
  • ChatterjeeDKRufaihahAJZhangYUpconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystalsBiomaterials200829793794318061257
  • WangCChengLLiuZDrug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapyBiomaterials20113241110112020965564
  • ChenGQiuHPrasadPNChenXUpconversion nanoparticles: design, nanochemistry, and applications in theranosticsChem Rev2014114105161521424605868
  • ChanYCChenCWChanMHMMP2-sensing up-conversion nanoparticle for fluorescence biosensing in head and neck cancer cellsBiosens Bioelectro201680131139
  • RaoLMengQFBuLLErythrocyte membrane-coated upconversion nanoparticles with minimal protein adsorption for enhanced tumor imagingACS Appl Mater Interfaces2017932159216828050902
  • ColleyHEHearndenVAvila-OliasMPolymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluationMol Pharm20141141176118824533501
  • SaiyinWWangDLiLSequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapyMol Pharm20141151662167524666011
  • EndoKUenoTKondoSTumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinomaCancer Sci2013104336937423216802
  • BraicuCGhermanCEpigallocatechin gallate induce cell death and apoptosis in triple negative breast cancer cells Hs578TJ Drug Target Epub20121119
  • BraicuCGhermanCDIrimieABerindan-NeagoeIEpigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cellsJ Nanosci Nanotechnol201313163263723646788
  • LiuXHuangHWangJDendrimers-delivered short hairpin RNA targeting hTERT inhibits oral cancer cell growth in vitro and in vivoBiochem Pharmacol2011821172321453684
  • LinHYThomasJLChenHWShenCMYangWJLeeMHIn vitro suppression of oral squamous cell carcinoma growth by ultrasound-mediated delivery of curcumin microemulsionsInt J Nanomedicine2012794195122393291
  • GavinAPhamJTWangDBrownlowBElbayoumiTALayered nanoemulsions as mucoadhesive buccal systems for controlled delivery of oral cancer therapeuticsInt J Nanomedicine2015101569158425759580
  • ImaiMIshibashiHNariaiYTransfection of hypoxia-inducible factor-1 decoy oligodeoxynucleotides suppresses expression of vascular endothelial growth factor in oral squamous cell carcinoma cellsJ Oral Pathol Med201241967568122582814
  • HolpuchASHummelGJTongMNanoparticles for local drug delivery to the oral mucosa: proof of principle studiesPharm Res20102771224123620354767
  • AfifiMMAustinLAMackeyMAEl-SayedMAXAV939: from a small inhibitor to a potent drug bioconjugate when delivered by gold nanoparticlesBioconjug Chem201425220721524409808
  • FekrazadRHakimihaNFarokhiETreatment of oral squamous cell carcinoma using anti-HER2 immunonanoshellsInt J Nanomedicine201162749275522131825
  • SongWZGongJXWangYQGold nanoflowers with mesoporous silica as “nanocarriers” for drug release and photothermal therapy in the treatment of oral cancer using near-infrared (NIR) laser lightJ Nanopart Res201618101
  • SulfikkaraliNKrishnakumarNManoharanSNirmalRMChemopreventive efficacy of naringenin-loaded nanoparticles in 7,12-dimethylbenz(a)anthracene induced experimental oral carcinogenesisPathol Oncol Res201319228729623233294
  • AbbasiMMMonfaredanAHamishehkarHSeidiKJahanban-EsfahlanRNovel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalitiesAsian Pac J Cancer Prev201415156227623225124602
  • LinMWangDLiuSCupreous complex-loaded chitosan nanoparticles for photothermal therapy and chemotherapy of oral epithelial carcinomaACS Appl Mater Interfaces2015737208012081226339804
  • KreimannELItoizMELonghinoJBlaumannHCalzettaOSchwintAEBoron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch modelCancer Res200161248638864211751376
  • MolinariAJThorpSIPortuAMAssessing advantages of sequential boron neutron capture therapy (BNCT) in an oral cancer model with normalized blood vesselsActa Oncol20155419910624960584
  • GarabalinoMAHeberEMMonti HughesABoron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPAAppl Radiat Isot201488646824360859
  • SuzukiMKatoIAiharaTBoron neutron capture therapy outcomes for advanced or recurrent head and neck cancerJ Radiat Res201455114615323955053
  • HeberEMKuefferPJLeeMWJrBoron delivery with liposomes for boron neutron capture therapy (BNCT): biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potentialRadiat Environ Biophys201251219520422271404
  • HeberEMHawthorneMFKuefferPJTherapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch modelProc Natl Acad Sci U S A201411145160771608125349432
  • SuganoMNegishiYEndo-TakahashiYGene delivery system involving Bubble liposomes and ultrasound for the efficient in vivo delivery of genes into mouse tongue tissueInt J Pharm20124221–233233722100513
  • LecarosRLHuangLLeeTCHsuYCNanoparticle delivered VEGF-A siRNA enhances photodynamic therapy for head and neck cancer treatmentMol Ther201624110611626373346
  • ChenWHLecarosRLTsengYCHuangLHsuYCNanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancerCancer Lett20153591657425596376
  • WangBWangJHLiuQRose-Bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapiesBiomaterials20143561954196624331707
  • PopovtzerAMizrachiAMotieiMActively targeted gold nanoparticles as novel radiosensitizer agents: an in vivo head and neck cancer modelNanoscale2016852678268526757746
  • GhermanCTudorMCConstantinBPharmacokinetics evaluation of carbon nanotubes using FTIR analysis and histological analysisJ Nanosci Nanotechnol20151542865286926353506
  • NeagoeIBBraicuCMateaCEfficient siRNA delivery system using carboxilated single-wall carbon nanotubes in cancer treatmentJ Biomed Nanotechnol20128456757422852466
  • DamascelliBPatelliGLLanocitaRA novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findingsAJR Am J Roentgenol2003181125326012818869
  • Al-GhananeemAMMalkawiAHMuammerYMIntratumoral delivery of paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulationsAAPS PharmSciTech200910241041719381833
  • DamascelliBPatelliGTichaVFeasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynxJ Vasc Interv Radiol200718111395140318003990
  • FuryMGShermanEJRaoSSPhase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)Ann Oncol201425368969424496920